Targeting KRAS in cancer
Anupriya Singhal, Bob T. Li & Eileen M. O’Reilly
Nature Magazine, April 18, 2024
This piece in Nature Medicine that outlines the strategic thinking and future directions in the KRAS battle. Combination therapies against KRAS are underway, and first-in-human clinical trials of new allele specific molecules are already here, including promising inhibitors of KRAS G12D.
Apart from furthering our advances against lung cancers, we have a comprehensive plan to beat some of the most recalcitrant malignancies.
